|
|
|
ONLINE FEATURES
Book Reviews
BW Video
Columnists
Interactive Gallery
Newsletters
Past Covers
Philanthropy
Podcasts
Special Reports
BLOGS
The Auto Beat
Byte of the Apple
Europe Insight
Eye on Asia
Getting In
Investing Insights
The New Entrepreneur
NEXT: Innovation Tools & Trends
On Media
Technology at Work
The Tech Beat
Traveler's Check
TECHNOLOGY
Product Reviews
Tech Stats
Hands On
AUTOS
Home Page
Auto Reviews
Car Care & Safety
INNOVATION
& DESIGN Home Page Architecture Brand Equity Auto Design Game Room SMALLBIZ Smart Answers Success Stories Today's Tip FINANCE Investing: Europe Annual Reports Bloomberg BW50 SCOREBOARDS Hot Growth Companies: 2008 Mutual Funds Info Tech 100 B-SCHOOLS Undergrad Programs Rankings & Profiles |  |
FEBRUARY 7, 2005
Why Arrowhead May Outshoot The Nanotechs  Nanotechnology, which involves the design of materials or devices at the molecular level, hasn't produced many big winners. One stellar performer, however, has been tiny Arrowhead Research (ARWR
), which topped other stocks in the Merrill Lynch (MER
) nanotech index. It zoomed from 1.95 in January, 2004, to 4.32 on Dec. 31. The volatile stock -- not for the faint of heart -- is now at 3.96. The index, made up of 27 nanotech stocks traded in the U.S., has been flat since its Apr. 1 launch. Arrowhead signed a pact in early 2004 with California Institute of Technology to fund Caltech's nanotech research in exchange for the rights to market future products. Karsten Siebert of Midas Research rates Arrowhead, which has yet to make a dime, a "speculative buy." The company could be the "wild card" among the nanotechs because of its close ties with Caltech, Siebert says. The analyst sees the stock hitting 6 in year. Arrowhead President Bruce Stewart says one product apt to hit the market late this year is an atomic force microscope probe, 1,000 times as sensitive as the existing ones. It lets scientists image and manipulate molecules and atoms in nano dimensions.
Note: Unless otherwise noted, neither the sources cited in Inside Wall Street nor their firms hold positions in the stocks under discussion. Similarly, they have no investment banking or other financial relationships with them.  By Gene G. Marcial Get BusinessWeek directly on your desktop with our RSS feeds.  Add BusinessWeek news to your Web site with our headline feed. Click to buy an e-print or reprint of a BusinessWeek or BusinessWeek Online story or video. To subscribe online to BusinessWeek magazine, please click here. Learn more, go to the BusinessWeekOnline home page  | | |
 Copyright 2005, Bloomberg L.P.Terms of Use | Privacy Notice |
Printer-Friendly Version
